Clinical Trial Update: Study of DC-CIK to Treat Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating dendritic cell-cytokine-induced killer (DC-CIK) therapy for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• DC-CIK therapy (dendritic cell-cytokine-induced killer cells)

Snippet

Sponsor: Guangxi Medical University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN